GlassScriptPhysician profile
Susan L Smith
NPI 1558570002
$2,275.75
in general payments reported to CMS, 2019-2025
14 companies · $718 in 2025
The $718 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $384 · 2022: $692 · 2023: $350 · 2024: $131 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149 · Education: $51.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.51 |
| Education | $51.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $533.11 | 2021-2025 | Biobrane, Oasis, Versajet |
| Paratek Pharmaceuticals, INC. | $277.49 | 2022-2023 | Nuzyra |
| Teva Pharmaceuticals USA, INC. | $231.09 | 2024-2025 | Austedo Xr |
| Gilead Sciences, INC. | $210.46 | 2021-2025 | Epclusa |
| Genzyme Corporation | $190.66 | 2022-2025 | |
| Grifols USA, LLC | $126.63 | 2022 | |
| Shield Therapeutics INC | $125.00 | 2023 | Accrufer |
| Axsome Therapeutics, INC. | $117.12 | 2025 | Auvelity |
| Genentech USA, INC. | $113.71 | 2021 | |
| Horizon Therapeutics Plc | $101.20 | 2022 | |
| Abiomed | $95.55 | 2025 | |
| Abbvie INC. | $88.53 | 2022 | |
| Novo Nordisk INC | $49.48 | 2025 | Wegovy |
| Mallinckrodt Hospital Products INC. | $15.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.